Grapes May Reduce Blood Pressure in Men with Metabolic Syndrome

Published Online: Friday, October 5, 2012
Follow Pharmacy_Times:
A study in the Journal of Nutrition has shown that polyphenols, the antioxidants found in fruits and vegetables, could have a beneficial effect in men with high blood pressure associated with metabolic syndrome. The antioxidants may improve the function of the veins and arteries through vasorelaxation, which in turn reduces resistance and pressure.

Twenty-five men aged 30 to 70 years with a diagnosis of metabolic syndrome were given 30 days of either freeze-dried grape polyphenol powder or placebo. Blood pressure and other markers for metabolic syndrome (including plasma glucose and triglyceride levels) were assessed at the end of the 30-day period. Participants who were given the polyphenol powder were seen to have a lower resting systolic blood pressure than those given placebo (122 ± 11 mm Hg and 128 ± 10 mm Hg, respectively). Although other parameters remained consistent between groups, the authors noted that consuming more polyphenols may potentially decrease heart disease risk.

Previous research has shown that lifestyle medications, such as carbohydrate-restricted diets, are the most effective in treating metabolic syndrome. Chronic administration of grape polyphenols may improve some of the components of the syndrome and reduce the risk of developing heart disease in the future.

Related Articles
The JNC 8 guidelines are based on 27 large clinical trials that are often discussed in isolation, but have never been aggregated into a single source until now.
Joseph Saseen, PharmD, FASHP, FCCP, FNLA, BCPS, CLS, professor in the Departments of Clinical Pharmacy and Family Medicine at University of Colorado Skaggs School of Pharmacy, talks about the role age plays in deciding blood pressure goals.
Accurate blood pressure measurement is key in detecting hypertensive disorders that contribute to more than half of all maternal deaths.
Actavis is seeking FDA approval for its generic version of Gilead Sciences’ Letairis pulmonary arterial hypertension treatment.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$